Endocision

Endocision is an Israeli medical technology company focused on enhancing the precision of cancer surgery through real-time tissue analysis. Founded by the team behind the MarginProbe system, the company has developed a next-generation intraoperative tool designed to identify cancerous tissue at the margins of a lumpectomy. The technology utilizes advanced dielectric spectroscopy to differentiate between healthy and malignant cells instantaneously during surgery. This immediate feedback allows surgeons to perform additional shavings during the initial procedure, thereby reducing the high rates of re-excision associated with breast-conserving surgery. Endocision's mission is to improve surgical outcomes and reduce the physical and emotional burden on cancer patients.